Search

Charles M Blazey

from San Francisco, CA
Age ~51
Get Report
Related to:
Willem MartinCameron D Martin, 26Deborah Blazey Martin, 58Jacqueline N Blazey, 81Frances D BlazeyWillard C BlazeyRichard N Blazey, 82Andrew T Levy, 54Christine F Blazey, 55
Connected to:
Brian I Blazey, 70Philip T Blazey, 92Randy A Blazian, 78Josie A Blazic, 86Kent Blazic, 59Aaron J Blazier, 52Bill Blazier, 55Dennis Blazier, 56Michele B Blazina, 58Dianne M Blazo, 65

Charles Blazey Phones & Addresses

  • 100 Valdez Ave, San Francisco, CA 94112
  • 201 Cornwall St, San Francisco, CA 94118
  • 201 Cornwall St #3, San Francisco, CA 94118
  • 2023 Parker St, Berkeley, CA 94704
  • 5907 Telegraph Ave, Oakland, CA 94609
  • Endicott, NY
  • Ithaca, NY
  • Piscataway, NJ
  • Penfield, NY
  • 171 Randall St, San Francisco, CA 94131

Work

Company: Exelixis Mar 2017 Position: Medical writing, senior director

Education

Degree: Bachelors, Bachelor of Arts School / High School: Cornell University 2015 to 2016

Skills

Medicinal Chemistry • Drug Discovery • Organic Synthesis • Organic Chemistry • Drug Development • Drug Design • Cancer • Chemistry • Heterocyclic Chemistry • Biomarker Discovery • Synthetic Organic Chemistry • Nmr • Lc Ms • Purification • Adme • Lead Change • Assay Development

Languages

English

Industries

Biotechnology

Public records

Vehicle Records

Charles Blazey

View page
Address:
171 Randall St, San Francisco, CA 94131
Phone:
(415) 285-8822
VIN:
3VWPL7AJ4CM603554
Make:
VOLKSWAGEN
Model:
JETTA
Year:
2012

Resumes

Resumes

Charles Blazey Photo 1

Medical Writing, Senior Director

View page
Location:
100 Valdez Ave, San Francisco, CA 94112
Industry:
Biotechnology
Work:
Exelixis
Medical Writing, Senior Director
Exelixis Oct 2012 - Sep 2014
Senior Medical Writer 2
Exelixis Oct 2012 - Sep 2014
Associate Medical Writing Director
Exelixis 2002 - 2012
Senior Scientist I
Merck 1995 - 1997
Research Assistant
Education:
Cornell University 2015 - 2016
Bachelors, Bachelor of Arts Cornell University Jan 1, 1991 - Dec 31, 1995
Bachelors, Bachelor of Arts, Chemistry University of California, Berkeley
Doctorates, Doctor of Philosophy, Organic Chemistry
Skills:
Medicinal Chemistry
Drug Discovery
Organic Synthesis
Organic Chemistry
Drug Development
Drug Design
Cancer
Chemistry
Heterocyclic Chemistry
Biomarker Discovery
Synthetic Organic Chemistry
Nmr
Lc Ms
Purification
Adme
Lead Change
Assay Development
Languages:
English

Publications

Us Patents

Raf Modulators And Methods Of Use

View page
US Patent:
7846959, Dec 7, 2010
Filed:
Mar 25, 2005
Appl. No.:
11/568789
Inventors:
Neel Kumar Anand - Burlingame CA, US
Charles M. Blazey - San Francisco CA, US
Owen Joseph Bowles - Pacifica CA, US
Joerg Bussenius - Foster City CA, US
Simona Costanzo - Los Altos CA, US
Jeffry Kimo Curtis - San Anselmo CA, US
Larisa Dubenko - San Francisco CA, US
Abigail R. Kennedy - Oakland CA, US
Steven Charles Defina - Burlingame CA, US
Angie I. Kim - San Mateo CA, US
Jean-Claire L. Manalo - Daly City CA, US
Csaba J. Peto - Alameda CA, US
Kenneth D. Rice - San Rafael CA, US
Tsze H. Tsang - El Cerrito CA, US
Anagha Abhijit Joshi - Fremont CA, US
Assignee:
Exelixis, Inc. - South San Francisco CA
International Classification:
C07D 231/02
US Classification:
514405, 514403, 548356, 5483601, 5483611
Abstract:
The present invention relates to compounds of the Formula I, wherein G, A, X1, X2, X3, Z, E, Y, and X are defined herein. The compounds modulate protein kinase enzymatic activity to modulate cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Raf. Methods of using and preparing the compounds, and pharmaceutical compositions thereof, to treat kinase-dependent diseases and conditions are also an aspect of the invention.

Anaplastic Lymphoma Kinase Modulators And Methods Of Use

View page
US Patent:
7872014, Jan 18, 2011
Filed:
Jul 23, 2004
Appl. No.:
10/565657
Inventors:
Neel Kumar Anand - Burlingame CA, US
Charles M. Blazey - San Francisco CA, US
Owen Joseph Bowles - Pacifica CA, US
Joerg Bussenius - Foster City CA, US
Simona Costanzo - Los Altos CA, US
Jeffry Kimo Curtis - San Anselmo CA, US
Larisa Dubenko - San Francisco CA, US
Abigail R. Kennedy - Oakland CA, US
Richard G. Khoury - Redwood City CA, US
Angie I. Kim - San Mateo CA, US
Jean-Claire L. Manalo - Daly City CA, US
Csaba J. Peto - Alameda CA, US
Kenneth D. Rice - San Rafael CA, US
Tsze H. Tsang - El Cerrito CA, US
Assignee:
Exelixis, Inc. - South San Francisco CA
International Classification:
C07D 471/02
A61K 31/4745
US Classification:
514291, 514292, 546 82
Abstract:
The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.

Azetidines As Mek Inhibitors For The Treatment Of Proliferative Diseases

View page
US Patent:
7915250, Mar 29, 2011
Filed:
May 5, 2010
Appl. No.:
12/774544
Inventors:
Naing Aay - San Mateo CA, US
Neel Kumar Anand - Burlingame CA, US
Charles M. Blazey - San Francisco CA, US
Owen Joseph Bowles - Pacifica CA, US
Joerg Bussenius - Foster City CA, US
Simona Costanzo - Los Altos CA, US
Jeffry Kimo Curtis - San Anselmo CA, US
Steven Charles DeFina - Burlingame CA, US
Larisa Dubenko - San Francisco CA, US
Anagha Abhijit Joshi - Fremont CA, US
Abigail R. Kennedy - Oakland CA, US
Angie Inyoung Kim - San Mateo CA, US
Elena S. Koltun - Foster City CA, US
Jean-Claire Limun Manalo - Daly City CA, US
Csaba J. Peto - Alameda CA, US
Kenneth D. Rice - San Rafael CA, US
Tsze H. Tsang - El Cerrito CA, US
Assignee:
Exelixis, Inc. - South San Francisco CA
International Classification:
A61K 31/397
A61K 31/50
A61K 31/505
A61K 31/4523
A61K 31/4178
US Classification:
51421018, 514248, 51425203, 51425205, 514256, 514318, 514403, 544235, 544242, 544333, 544405, 546208, 546210, 5462681, 5462684, 5462754
Abstract:
Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.

Tropane Compounds

View page
US Patent:
8012956, Sep 6, 2011
Filed:
Oct 27, 2008
Appl. No.:
12/290159
Inventors:
Kenneth D. Rice - San Rafael CA, US
Naing Aay - San Mateo CA, US
Neel Kumar Anand - Burlingame CA, US
Arlyn Arcalas - South San Francisco CA, US
Charles M. Blazey - San Francisco CA, US
Owen Joseph Bowles - Pacifica CA, US
Chris A. Buhr - Redwood City CA, US
Joerg Bussenius - Foster City CA, US
Simona Costanzo - Los Altos CA, US
Jeffrey Kimo Curtis - San Anselmo CA, US
Steven Charles Defina - Burlingame CA, US
Larisa Dubenko - San Francisco CA, US
Abigail R. Kennedy - Oakland CA, US
Angie Inyoung Kim - San Mateo CA, US
Katherine Lara - San Mateo CA, US
Sunghoon Ma - Foster City CA, US
Jean-Claire Limun Manalo - Daly City CA, US
Csaba J. Peto - Alameda CA, US
Tsze H. Tsang - El Cerrito CA, US
Longcheng Wang - Palo Alto CA, US
Assignee:
Exelixis, Inc. - South San Francisco CA
International Classification:
A61K 31/46
A61K 31/5377
A61K 31/496
A61K 31/497
C07D 451/04
US Classification:
51421021, 5142332, 51425304, 51425505, 514304, 546124, 546125, 544127, 544362, 544405
Abstract:
A compound according to Formula I or II:.

Kinase Modulators And Methods Of Use

View page
US Patent:
8076338, Dec 13, 2011
Filed:
Apr 22, 2005
Appl. No.:
11/568173
Inventors:
Neel K. Anand - Burlingame CA, US
Charles M. Blazey - San Francisco CA, US
Owen Joseph Bowles - Pacifica CA, US
Joerg Bussenius - Foster City CA, US
Lynne Canne Bannen - Pacifica CA, US
Diva Sze-Ming Chan - San Francisco CA, US
Baili Chen - Palo Alto CA, US
Erick Wang Co - San Diego CA, US
Simona Costanzo - Los Altos CA, US
Steven Charles Defina - Burlingame CA, US
Larisa Dubenko - San Francisco CA, US
Maurizio Franzini - San Francisco CA, US
Ping Huang - Mountain View CA, US
Vasu Jammalamadaka - Pleasonton CA, US
Richard George Khoury - Redwood City CA, US
Moon Hwan Kim - Palo Alto CA, US
Rhett Ronald Klein - Chicago IL, US
Donna Tra Le - San Jose CA, US
Morrison B. Mac - San Francisco CA, US
John M. Nuss - Danville CA, US
Jason Jevious Parks - Sacramento CA, US
Kenneth D. Rice - San Rafael CA, US
Tsze H. Tsang - El Cerrito CA, US
Amy Lew Tsuhako - Milpitas CA, US
Yong Wang - Foster City CA, US
Wei Xu - Danville CA, US
Assignee:
Exelixis, Inc. - South San Francisco CA
International Classification:
A61K 31/501
A61K 31/497
C07D 473/16
C07D 401/04
US Classification:
51425202, 51425216, 544277, 544238, 544363
Abstract:
The present invention relates to compounds of the Formula (I) and (II) wherein R, R, R-R, m, n, X-X, and Qare defined herein. The compounds modulate protein kinase enzymatic activity to modulate cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly p70S6 and/or Akt kinases. Methods of using and preparing the compounds, and pharmaceutical compositions thereof, to treat kinase-dependent diseases and conditions are also an aspect of the invention.

Pyrimidinones As Casein Kinase Ii (Ck2) Modulators

View page
US Patent:
8101625, Jan 24, 2012
Filed:
Oct 23, 2006
Appl. No.:
12/083749
Inventors:
Kenneth D. Rice - San Rafael CA, US
Neel Kumar Anand - Burlingame CA, US
Arlyn Arcalas - South San Francisco CA, US
Charles M. Blazey - San Francisco CA, US
Joerg Bussenius - Foster City CA, US
Wai Ki Vicky Chan - San Francisco CA, US
Hongwang Du - Millbrae CA, US
Sergey Epshteyn - Fremont CA, US
Mohamed Abdulkader Ibrahim - Mountain View CA, US
Patrick Kearney - San Francisco CA, US
Abigail R. Kennedy - Oakland CA, US
Moon Hwan Kim - Palo Alto CA, US
Jean-Claire Limun Manalo - Daly City CA, US
Csaba J. Peto - Alameda CA, US
Tsze H. Tsang - El Cerrito CA, US
Amy Lew Tsuhako - Milpitas CA, US
Peiwen Zhou - Palo Alto CA, US
Elena S. Koltun - Foster City CA, US
Assignee:
Exelixis, Inc. - South San Francisco CA
International Classification:
A61K 31/505
C07D 239/02
US Classification:
514274, 544316
Abstract:
A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, Rand Rare defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.

Azetidines As Mek Inhibitors For The Treatment Of Proliferative Diseases

View page
US Patent:
8362002, Jan 29, 2013
Filed:
Mar 15, 2011
Appl. No.:
13/048832
Inventors:
Naing Aay - San Mateo CA, US
Neel Kumar Anand - Burlingame CA, US
Charles M. Blazey - San Francisco CA, US
Owen Joseph Bowles - Pacifica CA, US
Joerg Bussenius - Foster City CA, US
Simona Costanzo - Los Altos CA, US
Jeffry Kimo Curtis - San Anselmo CA, US
Steven Charles DeFina - Burlingame CA, US
Larisa Dubenko - San Francisco CA, US
Anagha Abhijit Joshi - Fremont CA, US
Abigail R. Kennedy - Oakland CA, US
Angie Inyoung Kim - San Mateo CA, US
Elena S. Koltun - Foster City CA, US
Jean-Claire Limun Manalo - Daly City CA, US
Csaba J. Peto - Alameda CA, US
Kenneth D. Rice - San Rafael CA, US
Tsze H. Tsang - El Cerrito CA, US
Assignee:
Exelixis, Inc. - San Francisco CA
International Classification:
A61K 31/397
A61K 31/50
A61K 31/505
A61K 31/4523
A61K 31/4178
US Classification:
51421018, 514248, 51425203, 51425205, 514256, 514318, 514403, 544235, 544242, 544333, 544405, 546208, 546210, 5462681, 5462684, 5462754
Abstract:
Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.

Benzoxazepines As Inhibitors Of Pi3K/Mtor And Methods Of Their Use And Manufacture

View page
US Patent:
8648066, Feb 11, 2014
Filed:
May 20, 2010
Appl. No.:
12/784254
Inventors:
Neel Kumar Anand - Burlingame CA, US
Charles M. Blazey - San Francisco CA, US
Owen Joseph Bowles - Pacifica CA, US
Chris Allen Buhr - Redwood City CA, US
Joerg Bussenius - Foster City CA, US
Jeffry Kimo Curtis - San Anselmo CA, US
Steven Charles DeFina - Burlingame CA, US
Larisa Dubenko - San Francisco CA, US
Jason R. Harris - San Bruno CA, US
Anagha Joshi - Fremont CA, US
Angie Inyoung Kim - San Mateo CA, US
Amy Lew Tsuhako - Milpitas CA, US
Sunghoon Ma - Foster City CA, US
Jean-Claire Limun Manalo - Daly City CA, US
Stephanie Ng - Palo Alto CA, US
Csaba J. Peto - Alameda CA, US
Kenneth D. Rice - San Rafael CA, US
Tsze H. Tsang - El Cerrito CA, US
Cristiana A. Zaharia - Redwood City CA, US
Assignee:
Exelixis, Inc. - South San Francisco CA
International Classification:
A61P 35/00
A61K 31/553
C07D 267/14
US Classification:
51421109, 540552
Abstract:
The invention is directed to Compounds of Formula I:.
Control profile
Charles M Blazey from San Francisco, CA, age ~51 Get Report